ロード中...

Are aromatase inhibitors associated with higher myocardial infarction risk in breast cancer patients? A Medicare population‐based study

BACKGROUND: Theoretically, the estrogen deprivation induced by aromatase inhibitors (AIs) might cause ischemic heart disease, but empiric studies have shown mixed results. We aimed to compare AIs and tamoxifen with regard to cardiovascular events among older breast cancer patients outside of clinica...

詳細記述

保存先:
書誌詳細
出版年:Clin Cardiol
主要な著者: Kamaraju, Sailaja, Shi, Yushu, Smith, Elizabeth, Nattinger, Ann B., Laud, Purushottam, Neuner, Joan
フォーマット: Artigo
言語:Inglês
出版事項: Wiley Periodicals, Inc. 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6344290/
https://ncbi.nlm.nih.gov/pubmed/30443921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23114
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!